Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.58 EUR | +2.78% | +0.16% | +28.11% |
May. 20 | BTIG Initiates Abivax at Buy Rating With $43 Price Target | MT |
May. 08 | Abivax: four abstracts to be presented on obefazimod | CF |
Evolution of the average Target Price on Abivax
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Abivax
BTIG | |
Guggenheim | |
Piper Sandler | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- ABVX Stock
- Consensus Abivax